Scioto Biosciences, Inc Email Format

Biotechnology ResearchIndiana, United States2-10 Employees

Scioto Biosciences, Inc. is a clinical-stage biotechnology company focused on microbiome therapeutics, aiming to deliver live therapeutic bacteria to the gut through an Activated Bacterial Therapeutics platform. Its work centers on activating beneficial gut bacteria to advance healing across gastrointestinal, oncology, and central nervous system indications, with the potential to address multiple disease areas through microbiome-based interventions.
Based in Indianapolis, Indiana, the company operates with a compact team and has pursued a phase Ib clinical program for its lead product SB-121 targeting autistic disorder. The organization positions itself within the biotechnology research sector as a developer of advanced bacterial therapeutics, pursuing development and clinical testing to bring novel microbiome-based treatments forward. Acknowledging its recent strategic activities, the company has been described in industry coverage as advancing gut-brain therapeutic research and microbial therapies for brain-related conditions.

Sign up for free to view info

Company overview Employee directory